vs

Side-by-side financial comparison of COHEN & STEERS, INC. (CNS) and Claritev Corp (CTEV). Click either name above to swap in a different company.

Claritev Corp is the larger business by last-quarter revenue ($246.6M vs $143.8M, roughly 1.7× COHEN & STEERS, INC.). COHEN & STEERS, INC. runs the higher net margin — 24.3% vs -32.7%, a 56.9% gap on every dollar of revenue. On growth, Claritev Corp posted the faster year-over-year revenue change (6.2% vs 2.9%). Claritev Corp produced more free cash flow last quarter ($36.4M vs $-126.4M). Over the past eight quarters, COHEN & STEERS, INC.'s revenue compounded faster (8.3% CAGR vs 2.5%).

Cohen & Steers is an American investment management company. It focuses on investments in real estate securities via real estate investment trusts (REIT) and alternative income via preferred securities.

CNS vs CTEV — Head-to-Head

Bigger by revenue
CTEV
CTEV
1.7× larger
CTEV
$246.6M
$143.8M
CNS
Growing faster (revenue YoY)
CTEV
CTEV
+3.3% gap
CTEV
6.2%
2.9%
CNS
Higher net margin
CNS
CNS
56.9% more per $
CNS
24.3%
-32.7%
CTEV
More free cash flow
CTEV
CTEV
$162.8M more FCF
CTEV
$36.4M
$-126.4M
CNS
Faster 2-yr revenue CAGR
CNS
CNS
Annualised
CNS
8.3%
2.5%
CTEV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CNS
CNS
CTEV
CTEV
Revenue
$143.8M
$246.6M
Net Profit
$34.9M
$-80.6M
Gross Margin
Operating Margin
28.0%
-3.1%
Net Margin
24.3%
-32.7%
Revenue YoY
2.9%
6.2%
Net Profit YoY
-23.9%
41.6%
EPS (diluted)
$0.67
$-4.88

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNS
CNS
CTEV
CTEV
Q4 25
$143.8M
$246.6M
Q3 25
$141.7M
$246.0M
Q2 25
$136.1M
$241.6M
Q1 25
$134.5M
$231.3M
Q4 24
$139.8M
$232.1M
Q3 24
$133.2M
$230.5M
Q2 24
$121.7M
$233.5M
Q1 24
$122.7M
$234.5M
Net Profit
CNS
CNS
CTEV
CTEV
Q4 25
$34.9M
$-80.6M
Q3 25
$41.7M
$-69.8M
Q2 25
$36.8M
$-62.6M
Q1 25
$39.8M
$-71.3M
Q4 24
$45.8M
$-138.0M
Q3 24
$39.7M
$-391.4M
Q2 24
$31.8M
$-576.7M
Q1 24
$34.0M
$-539.7M
Operating Margin
CNS
CNS
CTEV
CTEV
Q4 25
28.0%
-3.1%
Q3 25
34.5%
4.1%
Q2 25
31.8%
6.9%
Q1 25
33.6%
4.2%
Q4 24
35.3%
-17.8%
Q3 24
33.7%
-146.7%
Q2 24
31.5%
-224.4%
Q1 24
32.8%
-207.4%
Net Margin
CNS
CNS
CTEV
CTEV
Q4 25
24.3%
-32.7%
Q3 25
29.4%
-28.4%
Q2 25
27.1%
-25.9%
Q1 25
29.6%
-30.8%
Q4 24
32.8%
-59.4%
Q3 24
29.8%
-169.8%
Q2 24
26.1%
-247.0%
Q1 24
27.7%
-230.1%
EPS (diluted)
CNS
CNS
CTEV
CTEV
Q4 25
$0.67
$-4.88
Q3 25
$0.81
$-4.23
Q2 25
$0.72
$-3.81
Q1 25
$0.77
$-4.38
Q4 24
$0.89
$-8.49
Q3 24
$0.77
$-24.25
Q2 24
$0.63
$-35.78
Q1 24
$0.68
$-33.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNS
CNS
CTEV
CTEV
Cash + ST InvestmentsLiquidity on hand
$145.5M
$16.8M
Total DebtLower is stronger
$4.6B
Stockholders' EquityBook value
$562.0M
$-173.9M
Total Assets
$876.7M
$4.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNS
CNS
CTEV
CTEV
Q4 25
$145.5M
$16.8M
Q3 25
$98.1M
$39.2M
Q2 25
$95.4M
$56.4M
Q1 25
$65.2M
$23.1M
Q4 24
$183.0M
$16.8M
Q3 24
$106.5M
$86.6M
Q2 24
$122.0M
$48.8M
Q1 24
$99.5M
$58.7M
Total Debt
CNS
CNS
CTEV
CTEV
Q4 25
$4.6B
Q3 25
$4.5B
Q2 25
$4.5B
Q1 25
$4.5B
Q4 24
$4.5B
Q3 24
$4.5B
Q2 24
$4.5B
Q1 24
$4.5B
Stockholders' Equity
CNS
CNS
CTEV
CTEV
Q4 25
$562.0M
$-173.9M
Q3 25
$550.3M
$-101.8M
Q2 25
$528.5M
$-39.9M
Q1 25
$507.7M
$14.8M
Q4 24
$511.7M
$84.0M
Q3 24
$491.0M
$207.6M
Q2 24
$463.2M
$603.4M
Q1 24
$378.9M
$1.2B
Total Assets
CNS
CNS
CTEV
CTEV
Q4 25
$876.7M
$4.9B
Q3 25
$801.6M
$5.0B
Q2 25
$751.0M
$5.1B
Q1 25
$834.9M
$5.1B
Q4 24
$812.4M
$5.2B
Q3 24
$727.8M
$5.3B
Q2 24
$784.1M
$5.7B
Q1 24
$680.7M
$6.4B
Debt / Equity
CNS
CNS
CTEV
CTEV
Q4 25
Q3 25
Q2 25
Q1 25
304.87×
Q4 24
53.67×
Q3 24
21.73×
Q2 24
7.48×
Q1 24
3.85×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNS
CNS
CTEV
CTEV
Operating Cash FlowLast quarter
$-120.4M
$66.3M
Free Cash FlowOCF − Capex
$-126.4M
$36.4M
FCF MarginFCF / Revenue
-87.9%
14.8%
Capex IntensityCapex / Revenue
4.2%
12.1%
Cash ConversionOCF / Net Profit
-3.45×
TTM Free Cash FlowTrailing 4 quarters
$-253.6M
$-12.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNS
CNS
CTEV
CTEV
Q4 25
$-120.4M
$66.3M
Q3 25
$55.1M
$19.9M
Q2 25
$-67.6M
$61.2M
Q1 25
$-108.9M
$-30.1M
Q4 24
$96.7M
$-33.4M
Q3 24
$25.6M
$72.8M
Q2 24
$31.4M
$18.5M
Q1 24
$4.9M
$49.7M
Free Cash Flow
CNS
CNS
CTEV
CTEV
Q4 25
$-126.4M
$36.4M
Q3 25
$52.6M
$-16.3M
Q2 25
$-69.8M
$36.6M
Q1 25
$-110.0M
$-68.9M
Q4 24
$85.0M
$-63.8M
Q3 24
$24.2M
$41.1M
Q2 24
$27.1M
$-7.0M
Q1 24
$537.0K
$19.2M
FCF Margin
CNS
CNS
CTEV
CTEV
Q4 25
-87.9%
14.8%
Q3 25
37.1%
-6.6%
Q2 25
-51.3%
15.2%
Q1 25
-81.8%
-29.8%
Q4 24
60.8%
-27.5%
Q3 24
18.2%
17.8%
Q2 24
22.3%
-3.0%
Q1 24
0.4%
8.2%
Capex Intensity
CNS
CNS
CTEV
CTEV
Q4 25
4.2%
12.1%
Q3 25
1.8%
14.7%
Q2 25
1.6%
10.2%
Q1 25
0.8%
16.8%
Q4 24
8.3%
13.1%
Q3 24
1.1%
13.8%
Q2 24
3.5%
10.9%
Q1 24
3.5%
13.0%
Cash Conversion
CNS
CNS
CTEV
CTEV
Q4 25
-3.45×
Q3 25
1.32×
Q2 25
-1.84×
Q1 25
-2.74×
Q4 24
2.11×
Q3 24
0.65×
Q2 24
0.99×
Q1 24
0.14×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons